Provided by Tiger Trade Technology Pte. Ltd.

PHARMARON

29.380
+0.2800.96%
Volume:4.95M
Turnover:145.62M
Market Cap:53.91B
PE:26.74
High:29.880
Open:28.900
Low:28.720
Close:29.100
52wk High:34.860
52wk Low:14.289
Shares:1.84B
HK Float Shares:358.00M
Volume Ratio:0.79
T/O Rate:1.38%
Dividend:0.23
Dividend Rate:0.78%
EPS(LYR):1.099
ROE:10.11%
ROA:4.87%
PB:2.82
PE(LYR):26.74
PS:3.02

Loading ...

PHARMARON posts 2025 Annual and ESG reports online; shareholders may request free printed copies

Bulletin Express
·
Apr 28

Pharmaron 2025年报:营收达140.951亿元,IFRS净利同比下滑7.2%,多元化研发格局稳步拓展

Bulletin Express
·
Apr 28

Stock Track | Pharmaron Soars 6.60% Intraday as Biotech Sector Rallies on Wuxi Apptec's Strong Earnings

Stock Track
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

JPMorgan Reduces Stake in Pharmaron by Approximately 605,000 Shares at HK$21.39 Per Share

Stock News
·
Apr 22

CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase

Stock News
·
Apr 17

Pharmaron Beijing Sets 28 April 2026 Board Meeting to Approve Q1 2026 Results

Bulletin Express
·
Apr 14

Morgan Stanley Raises Pharmaron Target Price to HK$31.5, Keeps Overweight Rating

Stock News
·
Apr 14

HK Movers | Pharmaceutical Stocks Rally With Joinn up 7%

Tiger Newspress
·
Apr 09

IEA Warns of Doubling Oil Supply Gap in April; US Launches Manned Moon Mission Rocket

Stock News
·
Apr 02

Stock Track | PHARMARON Soars 11.69% Intraday on Strong Q4 Earnings and Robust New Order Growth

Stock Track
·
Apr 01

PHARMARON Shares Surge Over 7% on Strong Performance Acceleration and Double-Digit New Order Growth

Stock News
·
Apr 01

Stock Track | PHARMARON Soars 5.09% Intraday on Capital Increase and Dividend Proposal

Stock Track
·
Mar 31

PHARMARON Proposes Capital Increase

Stock News
·
Mar 31

Pharmaron Reports 2025 Financial Results with Net Profit Decline

Stock News
·
Mar 30

Pharmaron to Elevate Registered Capital to RMB 1.84 Billion and Appoints New Company Secretary

Bulletin Express
·
Mar 30

Pharmaron Proposes Final Cash Dividend of RMB2 per 10 Shares for FY2025

Bulletin Express
·
Mar 30

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

Beijing Economic Zone Launches Two New Bus Routes Today

Deep News
·
Mar 26